These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18024605)

  • 1. Aplastic anemia: pathogenesis and treatment.
    Bacigalupo A
    Hematology Am Soc Hematol Educ Program; 2007; ():23-8. PubMed ID: 18024605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The use of allogeneic bone marrow transplantation and immunosuppressive therapy in the treatment of patients with acquired aplastic anemia].
    Ganapiev AA; Golubovskaia IK; Zalialov IuR; Estrina MA; Afanas'ev BV
    Ter Arkh; 2010; 82(7):48-52. PubMed ID: 20853609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transplantation of the bone marrow from a HLA-compatible unrelated donor after immunoablative conditioning in children with acquired aplastic anemia unresponsive to combined immunosuppressive therapy: preliminary results].
    Novichkova GA; Maschan MA; Shipitsyna IP; Skvortsova IuV; Persiantseva MI; Lebedeva LL; Bobrynina VO; Baĭdil'dina DD; Goronkova OV; Solopova GG; Khachatrian LA; Petrova UN; Suntsova EV; Kalinina II; Sinitsyna VV; Skorobogatova EV; Balashov DN; Dyshlevaia ZM; Shelikhova LN; Kurnikova EE; Trakhtman PE; Maschan AA
    Ter Arkh; 2010; 82(7):41-7. PubMed ID: 20853608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic hematopoietic stem cell transplantation is superior to immunosuppressive therapy in Indian children with aplastic anemia--a single-center analysis of 100 patients.
    George B; Mathews V; Viswabandya A; Lakshmi KM; Srivastava A; Chandy M
    Pediatr Hematol Oncol; 2010 Mar; 27(2):122-31. PubMed ID: 20201693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT.
    Dufour C; Veys P; Carraro E; Bhatnagar N; Pillon M; Wynn R; Gibson B; Vora AJ; Steward CG; Ewins AM; Hough RE; de la Fuente J; Velangi M; Amrolia PJ; Skinner R; Bacigalupo A; Risitano AM; Socie G; Peffault de Latour R; Passweg J; Rovo A; Tichelli A; Schrezenmeier H; Hochsmann B; Bader P; van Biezen A; Aljurf MD; Kulasekararaj A; Marsh JC; Samarasinghe S
    Br J Haematol; 2015 Nov; 171(4):585-94. PubMed ID: 26223288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aplastic anemia: pathophysiology and treatment.
    Young NS; Bacigalupo A; Marsh JC
    Biol Blood Marrow Transplant; 2010 Jan; 16(1 Suppl):S119-25. PubMed ID: 19782144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic stem cell transplantation for aplastic anemia and paroxysmal nocturnal hemoglobinuria: current evidence and recommendations.
    Marotta S; Pagliuca S; Risitano AM
    Expert Rev Hematol; 2014 Dec; 7(6):775-89. PubMed ID: 25331515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired aplastic anemia in Korean children: treatment guidelines from the Bone Marrow Failure Committee of the Korean Society of Pediatric Hematology Oncology.
    Kook H; Chung NG; Kang HJ; Im HJ
    Int J Hematol; 2016 Apr; 103(4):380-6. PubMed ID: 26894608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Making therapeutic decisions in adults with aplastic anemia.
    Marsh J
    Hematology Am Soc Hematol Educ Program; 2006; ():78-85. PubMed ID: 17124044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the early cyclosporine A level predictive of the outcome of immunosuppressive therapy in severe aplastic anemia?
    Song MK; Chung JS; Joo YD; Kim YS; Kim SH; Seol YM; Shin HJ; Choi YJ; Cho GJ
    Eur J Haematol; 2009 Jul; 83(1):72-8. PubMed ID: 19220415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hematopoietic stem-cell transplantation in aplastic anemia].
    Hernández-Rivera EG
    Rev Invest Clin; 2005; 57(2):298-304. PubMed ID: 16524071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired Aplastic Anemia: What Have We Learned and What Is in the Horizon?
    Savaşan S
    Pediatr Clin North Am; 2018 Jun; 65(3):597-606. PubMed ID: 29803285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alemtuzumab, fludarabine and melphalan as a conditioning therapy in severe aplastic anemia and hypoplastic myelodysplastic syndrome--single center experience.
    Rzepecki P; Sarosiek T; Szczylik C
    Jpn J Clin Oncol; 2006 Jan; 36(1):46-9. PubMed ID: 16423840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of long-term outcome of children with severe aplastic anemia treated with immunosuppression versus bone marrow transplantation.
    Gillio AP; Boulad F; Small TN; Kernan NA; Reyes B; Childs BH; Brochstein JA; Laver J; Castro-Malaspina H; O'Reilly RJ
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):18-24. PubMed ID: 9209737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
    Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
    Klin Padiatr; 1998; 210(4):173-9. PubMed ID: 9743949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic stem cell transplantation from related and unrelated donors for aplastic anaemia in adults--a single-centre experience.
    Buchholz S; Dammann E; Koenecke Ch; Stadler M; Franzke A; Blasczyk R; Bremer M; Krauter J; Hertenstein B; Ganser A; Eder M
    Ann Hematol; 2008 Jul; 87(7):551-6. PubMed ID: 18386010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective survey on the prevalence and outcome of prior autoimmune diseases in patients with aplastic anemia reported to the registry of the European group for blood and marrow transplantation.
    Cesaro S; Marsh J; Tridello G; Rovò A; Maury S; Montante B; Masszi T; Van Lint MT; Afanasyev B; Iriondo Atienza A; Bierings M; Carbone C; Doubek M; Lanino E; Sarhan M; Risitano A; Steinerova K; Wahlin A; Pegoraro A; Passweg J
    Acta Haematol; 2010; 124(1):19-22. PubMed ID: 20606411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How I treat acquired aplastic anemia.
    Bacigalupo A
    Blood; 2017 Mar; 129(11):1428-1436. PubMed ID: 28096088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers.
    Storb R; Blume KG; O'Donnell MR; Chauncey T; Forman SJ; Deeg HJ; Hu WW; Appelbaum FR; Doney K; Flowers ME; Sanders J; Leisenring W
    Biol Blood Marrow Transplant; 2001; 7(1):39-44. PubMed ID: 11215697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithymocyte globulin and cyclosporine for treatment of 44 children with hepatitis associated aplastic anemia.
    Osugi Y; Yagasaki H; Sako M; Kosaka Y; Taga T; Ito T; Yamamoto M; Ohara A; Sato T; Mimaya J; Tsukimoto I; Kojima S;
    Haematologica; 2007 Dec; 92(12):1687-90. PubMed ID: 18055993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.